oxazoles has been researched along with Alloxan Diabetes in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Adeghate, E; Csekő, K; Dányádi, B; Deres, L; Ferdinandy, P; Gábriel, R; Halmosi, R; Helyes, Z; Horváth, ÁI; Kőszegi, T; Kovács-Valasek, A; Mátyus, P; Pintér, E; Sághy, É; Szabadfi, K; Tékus, V; Varga, ZV | 1 |
| Bajaj, M; Birnbaum, Y; Chen, H; Nanhwan, MK; Qian, J; Ye, Y | 1 |
| Kumar, AS; Kumar, PV; Ramu, P; Selvam, TP | 1 |
| Falk, E; Glien, M; Glombik, H; Herling, AW; Korn, M; Linz, W; Rütten, H; Schäfer, HL; Wendler, W | 1 |
| Das, N; Kumar, P; Moorthy, NS; Shrivastava, SK; Shukla, S; Srivastava, RS; Trivedi, P | 1 |
| Alonso-Magdalena, P; García-Arévalo, M; Gustafsson, JA; Muhammed, SJ; Nadal, A; Quesada, I; Ropero, AB; Salehi, A; Soriano, S | 1 |
| Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; Navarro-Cid, J; Sanz-Rosa, D; Vázquez-Cruz, B | 1 |
| Hazama, M; Maekawa, T; Momose, Y; Murase, K; Sakai, N; Sugiyama, Y; Tawada, H | 1 |
| Carrick, KM; Clifton, LG; Lin, P; McNulty, JA; Pahel, GL; Stimpson, SA; Strum, JC; Winegar, DA; Yang, B | 1 |
| Csallany, AS; Malejka-Giganti, D; Matter, B; Tretyakova, N | 1 |
| Abed, YA; Al-Abed, Y; Cvetkovic, I; Fresta, M; Harhaji, L; Kim, J; Maksimovic-Ivanic, D; Mangano, K; Miljkovic, D; Momcilovic, M; Nicoletti, F; Popadic, D; Stosic-Grujicic, S | 1 |
| Belder, R; Chen, S; Cheng, PT; Devasthale, P; Egan, D; Farrelly, D; French, M; Gu, L; Hariharan, N; Harrity, T; Janovitz, E; Kunselman, L; Peters, A; Ponticiello, R; Staal, A; Swartz, J; Taylor, S; Tozzo, E; Welzel, G; Whaley, J; Zebo, R | 1 |
| Ahmad, P; Kumar, A; Maurya, RA; Singh, AB; Srivastava, AK | 1 |
| Zhou, YZ; Zhu, QH | 1 |
| Berthault, MF; Dubar, M; Ferré, P; Ktorza, A; Morin, J; Pénicaud, L | 1 |
| Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Henke, BR; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Orband-Miller, LA; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM | 1 |
| Blanchard, SG; Boswell, EG; Brown, KK; Charifson, PS; Cobb, JE; Collins, JL; Cooper, JP; Dezube, M; Henke, BR; Hull-Ryde, EA; Lake, DH; Lenhard, JM; Oliver, W; Oplinger, J; Parks, DJ; Pentti, M; Plunket, KD; Tong, WQ | 1 |
| Czarnik, Z; Hanczakowska, M; Ptak, W | 1 |
| Ishikawa, A; Kuroiwa, Y; Misawa, S; Tanaka, E | 1 |
| Hasselblatt, A; Poser, W; Schwabe, U | 1 |
| Blickens, DA; Riggi, SJ | 1 |
| Eastwood, GR; Kellett, DN | 1 |
| Reissert, K; Rudas, B | 1 |
23 other study(ies) available for oxazoles and Alloxan Diabetes
| Article | Year |
|---|---|
Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats.
Topics: Amine Oxidase (Copper-Containing); Analgesics; Animals; Cell Adhesion Molecules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hydrazines; Insulin; Insulin-Secreting Cells; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oximes; Rats; Rats, Sprague-Dawley; Streptozocin | 2021 |
Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cardiovascular Agents; Cell Survival; Diabetes Mellitus, Experimental; Heart; Humans; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oxazoles; PPAR alpha; PPAR gamma; Protective Agents; Signal Transduction; Thiophenes | 2016 |
Synthesis, characterization, and antihyperglycemic activity of novel oxazolidine derivatives.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Oxazoles; Rats; Rats, Sprague-Dawley; Spectrum Analysis; Streptozocin; Sucrose | 2011 |
AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.
Topics: Animals; Benzoates; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Fenofibrate; Glucose; Humans; Hypoglycemic Agents; Lipid Metabolism; Lipids; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Oxazoles; PPAR alpha; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones | 2012 |
Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
Topics: Animals; Benzaldehydes; Computer Simulation; Coumarins; Diabetes Mellitus, Experimental; Esters; Hydantoins; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Models, Molecular; Oxazoles; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Streptozocin; Thiazolidinediones | 2012 |
Antidiabetic actions of an estrogen receptor β selective agonist.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Estrogen Receptor beta; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Niacinamide; Oxazoles; Phenols; Streptozocin | 2013 |
Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Male; Oligopeptides; Oxazoles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Endothelin; Receptors, Thromboxane A2, Prostaglandin H2; Renal Circulation; Thromboxane A2; Vascular Resistance; Vasoconstriction | 2002 |
Synthesis and biological activity of novel 5-(omega-aryloxyalkyl)oxazole derivatives as brain-derived neurotrophic factor inducers.
Topics: Alkanes; Animals; Blood Glucose; Body Weight; Brain Chemistry; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Neural Conduction; Neuroblastoma; Oxazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Stimulation, Chemical; Structure-Activity Relationship; Subcellular Fractions | 2003 |
PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Diabetes Mellitus, Experimental; Diet; Dose-Response Relationship, Drug; Insulin; Insulin Resistance; Male; Mice; Oxazoles; PPAR gamma; Rats; Rats, Sprague-Dawley; Rats, Zucker; Tyrosine; Vascular Endothelial Growth Factor A | 2005 |
Quantitative analysis of the oxidative DNA lesion, 2,2-diamino-4-(2-deoxy-beta-D-erythro-pentofuranosyl)amino]-5(2H)-oxazolone (oxazolone), in vitro and in vivo by isotope dilution-capillary HPLC-ESI-MS/MS.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Artifacts; Chromatography, High Pressure Liquid; Deoxyguanosine; Diabetes Mellitus, Experimental; DNA; DNA Damage; Female; Light; Liver; Nitrogen Radioisotopes; Nucleosides; Oxazoles; Oxazolone; Oxidation-Reduction; Oxidative Stress; Radioisotope Dilution Technique; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2006 |
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozoto
Topics: Acetates; Animals; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Cyclophosphamide; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunologic Factors; Inflammation Mediators; Islets of Langerhans; Male; Mice; Mice, Inbred CBA; Mice, Inbred NOD; Molecular Structure; Nitric Oxide; Oxazoles; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin | 2007 |
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
Topics: Animals; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Disease Progression; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glycine; Hypoglycemic Agents; Insulin; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Oxazoles; Pancreas; PPAR alpha; PPAR gamma; Triglycerides | 2007 |
Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
Topics: Animals; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Hypoglycemic Agents; Lipids; Mice; Oxazoles; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Structure-Activity Relationship; Triglycerides | 2009 |
[Toxicologic studies of dichlozoline fungicide in rats (author's transl)].
Topics: Animals; Cataract; Diabetes Mellitus, Experimental; Dimethadione; Female; Fungicides, Industrial; Male; Oxazoles; Proteinuria; Rats | 1981 |
[Effects of rilmenidine on rats made insulin resistant and hypertensive by a high fructose diet].
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Disease Models, Animal; Fructose; Hypertension; Insulin; Insulin Resistance; Oxazoles; Rats; Rats, Wistar; Rilmenidine | 1996 |
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
Topics: Administration, Oral; Aminopyridines; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Lipids; Male; Mice; Oxazoles; Propionates; Radioligand Assay; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Stereoisomerism; Structure-Activity Relationship; Transcription Factors; Transfection; Tyrosine | 1998 |
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
Topics: Administration, Oral; Animals; Benzoates; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Lipids; Male; Mice; ortho-Aminobenzoates; Oxazoles; Radioligand Assay; Rats; Receptors, Cytoplasmic and Nuclear; Solubility; Structure-Activity Relationship; Transcription Factors; Tyrosine | 1998 |
Contact sensitivity in alloxan-diabetic mice.
Topics: Animals; Antigens; Blood Glucose; Dermatitis, Contact; Diabetes Mellitus, Experimental; Ear; Female; Immunization, Passive; Insulin; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Organ Size; Oxazoles; Oxazolone; Spleen; Thymus Gland | 1975 |
Sex-related differences in hepatic drug-oxidizing capacity of streptozotocin-induced diabetic rats.
Topics: Animals; Antipyrine; Diabetes Mellitus, Experimental; Dimethadione; Female; Insulin; Male; Microsomes, Liver; Mixed Function Oxygenases; Oxazoles; Oxidation-Reduction; Rats; Rats, Inbred Strains; Sex Factors; Trimethadione | 1988 |
[The blood sugar lowering effect of sulfafurazole and sulfamethoxazole in the rat].
Topics: Animals; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Hepatectomy; Hypoglycemia; Male; Oxazoles; Rats; Sulfamethoxazole; Sulfisoxazole; Tolbutamide | 1969 |
Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
Topics: Animals; Blood Glucose; Carbamates; Carbohydrate Metabolism; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Glucosamine; Glycogen; Glycosuria; Guinea Pigs; Hyperglycemia; Hypoglycemia; Lactates; Liver Glycogen; Male; Mice; Nitroso Compounds; Obesity; Oxazoles; Phenformin; Pyridinium Compounds; Rats | 1971 |
Some effects of 3-chloroisoxazole-5-carboxylic acid on lipid and carbohydrate metabolism.
Topics: Adipose Tissue; Animals; Blood Glucose; Depression, Chemical; Diabetes Mellitus, Experimental; Diaphragm; Drug Antagonism; Epididymis; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucose; Growth Hormone; Insulin; Lipid Metabolism; Male; Oxazoles; Pyrazoles; Rabbits; Rats; Triglycerides | 1969 |
[Effect of antidiabetics on the fat metabolism of alloxan-diabetic rats].
Topics: Animals; Chronic Disease; Depression, Chemical; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glycerol; Hypoglycemic Agents; Male; Oxazoles; Tolbutamide | 1969 |